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ABSTRACT 
Discogenic differentiation  
of human bone marrow mesenchymal stem cell  
with Adenovirus mediated glucose transporter-1 and 
hypoxia inducible factor-1α gene therapy 
 
Byung Ho Lee 
Department of Medicine The Graduate School, Yonsei University  
 
(Directed by Professor Hwan-Mo Lee) 
 
With aging and degeneration, intervertebral discs (IVDs) undergo profound 
and substantial changes in morphology and biochemical composition. An 
ideal solution for managing disc degeneration would be to repair the IVDs, by 
producing discogenic matrix. Recently, various approaches to biological 
repair of the disc function are under investigation, which are gene therapy, 
growth factor injection, cell therapy and cell-based tissue engineering.  
Hypoxia inducible factor-1α (HIF-1α) is the key molecules regulating energy 
metabolism and survival in the nucleus pulposus (NP) cell. The expression of 
HIF was demonstrated in the NP cell of normal human IVDs and can be used 
as a phenotypic marker of NP cell. Hypoxia responsive glucose transporter-
2 
 
1(GLUT-1) is a facilitative glucose transporter in the NP cell and also can be 
used as a phenotypic marker of NP cell along with HIF-1α 
The discogenic induction from human bone marrow mesenchymal stem 
cell(BMSC) using adenoviral transduction of NP specific phenotypic factors 
of HIF-1α and GLUT-1 was investigated via in vitro and in vivo experiments.   
The BMSC was obtained from patients during surgery for lumbar spinal 
stenosis. Each control and experimental groups, in vitro and in vivo 
experiments were performed simultaneously. In vivo study, total of 6 
conditions including 1 positive control with NP cell and 1 negative control 
with BMSC alone were set by the combination of control, viral vector and 
transducted genes. All groups were consisted of BMSC, BMSC with Ad-mock, 
the NP cell, BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and BMSC 
with Ad-HIF-1α and Ad-GLUT-1 in order. The gene transduction using 
adenovirus and subsequent differentiation of BMSC into NP cell was 
confirmed by reverse-transcription polymerase chain reaction(RT-PCR) and 
histologic analyses. In vivo experiment, xenograft of alginate-BMSC complex 
on the back of mice (DVA/1J) was done. Mice were sacrificed at 2 weeks and 
3 
 
4 weeks after subcutaneous implantation of alginate-BMSC complexes. 
Analyses of each specimen including histologic test were done. The mRNA of 
matrix component including aggrecan and collagen type II in the 
differentiated NP cell was tested.  
In vitro result at 24 and 48 hours culture, the BMSC with Ad-HIF-1α or Ad-
GLUT-1 or both with Ad-HIF-1α and Ad-GLUT-1 groups showed increased 
mRNA expression of GLUT-1, aggrecan, and type II collagen compared to 
control and the expression level was comparable level of NP cell group. In 
HIF-1α mRNA expression, BMSC with Ad-HIF-1α, and the BMSC with Ad-
HIF-1α and Ad-GLUT-1 groups showed increased level of expression of HIF-
1α mRNA compared to those of other groups.   
Based on the different oxygen conditioned culture for 96 hours, expression of 
HIF-1α and GLUT-1 mRNA of normoxic-hypoxic group showed analogous 
pattern with that of continuous normoxic group. In matrix component mRNA 
expression, expression pattern of aggrecan and collagen type II mRNA was 
comparable with that of continuous hypoxic group. 
For in vivo study, the BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and 
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BMSC with Ad-HIF-1α and Ad-GLUT-1 groups showed positive stains for 
collagen type II and aggrecan, which were analogous to the NP cell group.  
In conclusion, transduction of each gene of the HIF-1α, GLUT-1 using 
adenovirus vector was proved to be effective to induce the differentiation of 
BMSC into discogenic phenotype in vitro and in vivo.  
 
 
 
 
 
 
 
 
 
--------------------------------------------------------------------------------------------- 
Key words : intervertebral disc, bone marrow derived mesenchymal stem cell, 
adenovirus, HIF-1 α, GLUT-1
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I. INTRODUCTION 
Low back pain affects up to 85% of people at some point during their lives, 
resulting in healthcare and related costs in the United States of $100 billion 
every year.
1-3
 Numerous studies have established a causal association between 
degeneration of the intervertebral discs (IVDs) and low back pain.
4-6
 Although 
disc degeneration is not commonly present until adulthood,
7
 Changes to the 
cellular microenvironment of the IVDs begin within just a few years of birth.
8
  
With aging and degeneration, IVDs undergo profound substantial, 
morphological and cellular change.
9, 10
 An ideal solution to managing IVDs 
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degeneration would be to repair the IVDs, producing a matrix with 
comparable or improved biological and biomechanical properties compared 
with the original.
11
 Recently, various approaches to biological repair and 
regeneration of the IVDs function are under investigation, including gene 
therapy,
12,13
 growth factor injection,
14
 cell therapy and cell-based tissue 
engineering.
11,15
  
  Bone marrow derived mesenchymal stem cells (BMSC) have several 
theoretical and practical advantage over fully differentiated cells for cell 
therapy and tissue engineering applications.
16
 Alternatively, cell populations 
within the IVD can be manipulated through gene therapy approaches, which 
involve the delivery of genes into cells through viral-vector-mediated gene 
transfer.
17
  
Hypoxia inducible factor-1 α (HIF-1 α) is the key molecules regulating energy 
metabolism and survival in the nucleus pulposus (NP).
18
 The expression of 
HIF was demonstrated in the NP cell of normal human IVDs and can be used 
as a phenotypic marker of NP cell.
19,20
  
Glucose is an essential substrate for NP cell; it is needed both for glycolytic 
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metabolism and the synthesis of glycoproteins and glycosaminoglycan, which 
are the key molecules in preserving the gelatinous nature of the NP. An 
integral part of the metabolic adaptation to hypoxia is activation of genes 
involved in promoting anaerobic glycolysis using hypoxia responsive glucose 
transporter-1(GLUT-1) facilitative glucose transport 
21
 and also can be used as 
a phenotypic marker of NP cell along with HIF-1α.20  
 In the present study, we hypothesize that the transduction of those NP cell 
specific HIF-1α and GLUT-1 gene via adenoviral vector would induce the 
differentiation of BMSC into the NP cell. The potentiality and efficiency in 
differentiation of BMSC into the NP cell via transduction of phenotype-
specific HIF-1 α and GLUT-1 gene were investigated both in vivo and in vitro.  
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II. MATERIALS AND METHODS  
The BMSCs were obtained from patients during surgery for lumbar spinal 
stenosis. Reflecting control and experimental group, in vitro and in vivo 
experiments were performed simultaneously. In vivo study, total of 6 
conditions including 1 positive control and 1 negative control were set by the 
combination of control, viral vector and transducted genes. All groups were 
consisted of BMSC, BMSC with Ad-mock, the NP cell, BMSC with Ad-HIF-
1α, BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 in 
order. Schematic diagram of the study design is shown in Figure 1. 
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Figure 1. Schematic diagram of study design.  
Both in vitro and in vivo experiments were executed simultaneously using 
adenoviral transduction of each HIF-1α and GLUT-1 gene alone or in 
combination into the BMSC. All groups were consisted of BMSC, BMSC with 
Ad-mock, the NP cell, BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and 
BMSC with Ad-HIF-1α and Ad-GLUT-1 in order. Gene-transducted BMSCs 
were cultured in vitro in hypoxic and normoxic conditions for 24 hours ,48 
hours and 96 hours. In vivo experiments, DVI/1J mice of 4 week-old were 
used for subcutaneous implantation of alginate and gene transducted BMSC 
complex. 
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 The gene transduction using adenovirus and subsequent differentiation of 
BMSCs into NP cells were confirmed by several studies such as reverse-
transcription polymerase chain reaction (RT-PCR), western blot and histologic 
analyses. The mRNA of matrix component including aggrecan and collagen 
type II in the differentiated NP cell was tested as described below.  
 
1. Isolation of the bone marrow mesenchymal stem cell (BMSC)  
To attain human BMSC, bone marrow was obtained from iliac crest puncture 
during surgery for lumbar spinal stenosis. All patients gave informed consent 
before sugery. Local Ethical Committee approval was obtained for the use of 
the sample for research. BMSCs were isolated using a Ficoll-paque (GE 
Healthcare Bio-science AB, Uppsala, Sweden) density gradient method. 
These cells were cultured in a 75 cm
2
 flask with minimum essential medium, 
a-modification, supplemented with 10% FBS, 1% v/v antibiotic-antimycotic, 
25㎍/㎖ ascorbic acid (Gibco-BRL, Grand Island, NY, USA), at 37 ℃ in a 
humid atmosphere containing 5% CO2. After 7 days, non-adherent cells were 
discarded and adherent cells were cultured in media supplemented and 
11 
 
medium changed every 2 days. 
 
2. Ad-HIF-1α and Ad-GLUT-1 constructs 
Two different adenoviral constructs were prepared for this study: Adenovirus 
HIF-1 construct (Ad-HIF-1) expressing hypoxia inducible factor-1a gene 
and adenovirus GLUT-1 construct (Ad-GLUT-1) expressing human glucose 
transport-1 gene. Each recombinant adenoviral vector contained dicistronic 
expression cassette in which the multiple cloning site was followed by the 
EMCV-IRES (Agilent technologies, USA), which directed translation of a 
humanized recombinant green fluorescent protein (hrGFP) from a marine 
organism as a second open reading frame. The interest gene was fused to three 
contiguous copies of the FLAG®  (Sigma, St. Louis, MO, USA) epitope.  
Recombinant virus was grown in transformed human embryonic kidney 293 
cells and purified using manufacturing instructions (Vivapure AdenoPACK, 
Sartorius stedim, Goettingen, Germany). Titers were determined by optical 
density at 260nm. 
 
12 
 
3. Adenoviral Transductions 
At confluence, the MSC cell cultures were rinsed with D-PBS (Gibco-BRL, 
Grand Island, NY, USA) and exposed to 2ml of DMEM-LG containing one 
dose of Ad-HIF-1 and Ad-GLUT-1 with 120 multiplicity of infection (MOI). 
All cells were incubated in 5% CO2 at 37° C incubator with humidity to 
prevent drying up during the transduction for one hour. Then culture medium 
was then added to each well, and the cells were further incubated in a 5% CO2 
at 37° C incubator with humidity.  
 
4. Cell cytotoxicity and proliferation  
A MTS (Invitrogen, Paisley, UK) assay for proliferation and cytotoxicity was 
used according to the manufacturers’ protocol. In brief, 30ul of MTS reagent 
was added to each well of a 48-well microtitre plate with 200 ㎕ of culture 
medium. The cells were incubated at 37 °C with 5% CO2 for 1 h. Absorbance 
was measured at 405 nm with an ELISA microplate reader (Model 550, Bio-
Rad).  
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5. Reverse-transcription polymerase chain reaction analysis for collagen type 
II, aggrecan, HIF-1α and GLUT-1 
Total RNA was isolated from BMSC using QIAGEN RNeasy mini kit 
(QIAGEN, Valencia, CA, USA) following manufacturer’s instructions. cDNA 
was prepared using Maxime RT premix kit (Intron, Korea). Total RNA (1 ㎍) 
was reverse transcribed in a final volume of 20㎕ using Oligo(dT) as primers. 
The cDNAs were amplified for collagen type II and aggrecan. Relative 
expression levels were calculated as a ratio to the average value of beta actin. 
The data was analyzed using TINA program. RT-PCR was done three times in 
vitro experiment, with the specimen of 24 hours and 48 hours culture under 
normoxic condition and specimen in the different oxygen condition after 96 
hours culture; 96 hours of continuous culture under normoxia, 48 hours 
culture under hypoxia after preceding 48 hours culture under normoxia, and 
continuous 96 hours culture under hypoxia.    
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6. Western blot 
Cell lysates were obtained from the specimen of 24 hours and 48 hours 
culture under normoxic condition and specimen in the different oxygen 
condition after 96 hours culture; 96 hours of continuous culture under 
normoxia, 48 hours culture under hypoxia after preceding 48 hours culture 
under normoxia, and continuous 96 hours culture under hypoxia. The lysates 
were fractionated on 8% sodium dodecyl sulfate–polyacrylamide gel using 
electrophoresis and transferred onto a polyvinylidene difluoride membrane 
(Millipore Corporation, Billerica, MA, USA) by electrotransfering. Proteins 
were immunoblotted with anti-HIF-1α (Cell Signaling Technology, Danvers, 
MA, USA), anti-GLUT-1 (NOVUS biological, Littleton, CO, USA) and anti-
FLAG (Sigma, St. Louis, MO, USA). The proteins were visualized with an 
enhanced chemiluminescence detection system (West-Zol

 plus, Intron 
Biotechnology, Korea) according to the manufacturing protocol. 
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7. Animal model 
A. Alginate bead preparation 
Alginate solution (2.0% w/v) was prepared by mixing alginic acid sodium salt 
from brown algae (medium viscosity, Sigma, St. Louis, MO, USA), 0.025M 
HEPES, and 0.15M NaCl in deionized water (pH 7.4), which was mildly 
heated on a hot plate to dissolve the alginate and then sterile filtered. Before 
cell encapsulation, the temperature of the alginate solution was equilibrated to 
37°C. A BMSC cell suspension in alginate solution at a density of 5x10
6
 
cells/mL, which was transduced by 120 MOI Ad- HIF-1α, Ad-GLUT-1, or 
PBS, was injected into a 200 mM CaCl2 solution (Sigma, St. Louis, MO, 
USA) using a 20-gauge needle. Alginate beads, 2–3 mm in diameter (100,000 
cells per bead), formed instantaneously and were incubated for 15 min in the 
CaCl2 solution. The alginate beads were rinsed twice with PBS and once with 
DMEM, and then placed into 6-well plates with 0.5 mL medium/bead. 
BMSCs encapsulated in the alginate beads were cultured in DMEM, 10% 
FBS and 25 g/ml L-ascorbic acid (Sigma, St. Louis, MO, USA) for 1day.  
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B. Xenograft study in mice 
For implantation into DVA/1J mice, the prepared alginate beads-BMSC 
constructs were grafted subcutaneously into the back of 4-week-old female 
DVA/1J mice through separate incision. Surgery was performed via 
intramuscular injection with zoletil (Zoletil 50,Virbac Laboratories, France) 
and rompun (Rompun

 injection, Korea). After implantation of alginate beads, 
all wounds were closed in a routine manner using Nylon 4.0 suture material. 
No secondary operations were performed in the sham. On 2 weeks and 4 
weeks, the mice were killed for analysis and the tissue is extracted.  
 
C. RT-PCR for collagen type 2, aggrecan and HIF-1α  
Total RNA was isolated from MSC using QIAGEN RNeasy mini kit 
(QIAGEN) following manufacturer’s instructions. cDNA was prepared using 
Maxime RT premix kit (Intron, Korea) according to the manufacturer’s 
instructions. The cDNAs were amplified for collagen type 2, aggrecan and 
HIF-1α. Relative expression levels were calculated as a ratio to the average 
value of beta actin. The data was analyzed using TINA program. 
17 
 
D. Histological Analysis 
After macroscopic evaluation, the tissues from back were individually 
processed for histological studies. Each tissue was fixed in 4% formaline, and 
10% sodium citrate for approximately 5 minutes and processed for paraffin-
embeded tissue and sectioning into sagittal sections (5 mm thick). Sections 
were stained with H & E(Sigma, St. Louis, MO, USA), collagen type 2 
(Chondris, Inc., Redmond, WA, USA), aggrecan (abcam

, cambridge, UK), 
STRO (R&D systems, Inc., Minneapolis, MN, USA), for mineralization and 
alcian blue (Sigma, St. Louis, MO, USA ) for evaluation.  
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III. RESULTS 
1. In vitro 
A. Cell cytotoxicity  
In cell cytotoxicity analysis, each group except the BMSC with Ad-HIF-1α 
and Ad-GLUT-1 group showed no significant difference. The BMSC with Ad-
HIF-1α and Ad-GLUT-1 showed highest cytotoxicity due to double dose of 
transducted adenovirus (240 MOI: multiplicity of infection) compared to 
those of other groups (120 MOI). (Figure 2) 
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Figure 2. Cell cytotoxicity in vitro. 
In cell cytotoxicity analysis, each group showed no significant difference 
between them except BMSC with Ad-HIF-1α and Ad-GLUT-1. BMSC with Ad-
HIF-1α and Ad-GLUT-1 showed highest cytotoxicity due to double dose of 
transducted adenovirus (240 MOI: multiplicity of infection) compared to those 
of other groups (120 MOI). Because of highest transducted viral dose, BMSC 
with Ad-HIF-1α and Ad-GLUT-1 showed the resultant lowest cell counts in all 
groups. MOI : multiplicity of infection (viral titer/cell number)  
 
 
 
 
 
 
 
 
20 
 
B. Cell proliferation  
In cell proliferation analysis, all of the BMSC groups showed comparable 
results at 7 days. NP cell group showed the highest cell proliferation at 7 days, 
which is shown in Figure 3.   
 
Figure.3 Cell proliferation in vitro.  
NP cell group showed the highest cell proliferation compared to other BMSC 
groups. Other groups showed comparable cellular proliferation rate at 7 days. 
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C . RT-PCR of HIF-1α and GLUT-1  
(A) Normoxic condition at 24 and 48 hours 
In normoxic condition at 24 hours, BMSC with Ad-HIF-1α and BMSC with 
Ad-HIF-1α and Ad-GLUT-1 group showed almost 19 fold and 22 fold 
increase in HIF-1α mRNA expression compared to that of BMSC. Also NP 
cell group showed 3 fold increase in HIF-1α mRNA expression.  
All groups revealed no significantly different level of mRNA expression of 
GLUT-1. It ranged from 5% to 40% increase of GLUT-1 mRNA expression  
compared to that of BMSC. (Figure 4)  
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Figure 4. RT-PCR result of HIF-1α and GLUT-1 at 24 hours in vitro culture in 
normoxic condition.  
In HIF-1α, BMSC with Ad-HIF-1α and BMSC with Ad-HIF-1α and Ad-GLUT-1 
group showed almost 19 fold and 22 fold increase in HIF-1α mRNA 
expression compared to that of BMSC. In GLUT-1 mRNA expression, all 
groups showed no significantly different level of mRNA expression ranged 
from 5% to 40% increase of GLUT-1 mRNA expression compared to that of 
BMSC.  
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In normoxic condition at 48 hours, NP cell, BMSC with Ad-HIF-1α and  
BMSC with Ad-HIF-1α and Ad-GLUT-1 group demonstrated 2 fold, 12 fold 
and 15 fold increase in HIF-1α mRNA expression compared to that of BMSC.  
In GLUT-1 mRNA expression, BMSC with Ad-mock and NP cell group 
showed 20% to 30% decrease in GLUT-1 mRNA expression compared to that 
of BMSC. Contrary to those, BMSC with Ad-GLUT-1 and BMSC with Ad-
HIF-1α and Ad-GLUT-1 revealed 10% and 15% increase in GLUT-1 mRNA 
expression compared to that of BMSC. BMSC with Ad-HIF-1α showed 
comparable level of GLUT-1 mRNA expression with BMSC. (Figure 5) 
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Figure 5. RT-PCR result of HIF-1α and GLUT-1 at 48 hours in vitro culture in 
normoxic condition.  
BMSC with Ad-HIF-1α and BMSC with Ad-HIF-1α and Ad-GLUT-1 group 
showed 12 fold and 15 fold increase in HIF-1α mRNA expression compared to 
that of BMSC.  
In GLUT-1 mRNA expression, BMSC with Ad-mock and NP cell group 
demonstrated 20% to 30% decrease but BMSC with Ad-GLUT-1 and BMSC 
with Ad-HIF-1α and Ad-GLUT-1 revealed 10% and 15% increase in GLUT-1 
mRNA expression compared to that of BMSC.  
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(B) Hypoxic conditions at 24 and 48 hours 
In vitro culture results for 24 hours and 48 hours in hypoxic condition were 
different from the results in normoxic condition.  
In hypoxic condition at 24 hours, BMSC with Ad-mock, BMSC with Ad-HIF-
1α, BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 
group showed each of 90%, 45%, 25% and 70% increase in HIF-1α mRNA 
expression compared to that of BMSC. But, NP cell group demonstrated 80% 
decrease in HIF-1α mRNA expression compared to that of BMSC.  
Only NP cell group demonstrated 120% increase in mRNA expression of 
GLUT-1 compared to that of BMSC. BMSC with Ad-mock demonstrated 
comparable level of GLUT-1 mRNA expression. BMSC with Ad-HIF-1α,  
BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 group 
revealed 40%, 90% and 80% decrease in GLUT-1 mRNA expression. These 
results of HIF-1α and GLUT-1 mRNA expression are shown in Figure 6.  
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Figure 6. RT-PCR result of HIF-1α and GLUT-1 at 24 hours in vitro culture in 
hypoxic condition.  
BMSC with Ad-mock, BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and  
BMSC with Ad-HIF-1α and Ad-GLUT-1 group showed each of 90%, 45%, 25% 
and 70% increase in HIF-1α mRNA expression compared to that of BMSC. 
But in the expression of GLUT-1 mRNA, only NP cell group showed 120% 
increase in mRNA expression of GLUT-1 compared to that of BMSC.  
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In vitro culture results for 48 hours in hypoxic condition were different from 
those of in vitro result for 24 hours. (Figure 7) In HIF-1α mRNA expression, 
BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-
1α and Ad-GLUT-1 groups showed each of 30%, 60% and 70% increase 
compared to that of BMSC. But, the BMSC with Ad-mock demonstrated 60% 
decrease in HIF-1α mRNA expression compared to that of BMSC. NP group 
showed no expression of HIF-1α mRNA in this condition. 
In GLUT-1 mRNA expression, NP cell group, BMSC with Ad-HIF-1α,  
BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 groups 
showed 37 fold, 4 fold, 6 fold, and 8 fold increase in mRNA expression of 
GLUT-1 compared to that of BMSC. BMSC with Ad-mock demonstrated no 
GLUT-1 mRNA expression.  
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Figure 7. RT-PCR result of HIF-1α and GLUT-1 at 48 hours in vitro culture in 
hypoxic condition.  
In HIF-1α mRNA expression, BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 
and BMSC with Ad-HIF-1α and Ad-GLUT-1 groups showed each of 30%, 60% 
and 70% increase in HIF-1α mRNA expression compared to that of BMSC. In 
GLUT-1 mRNA expression, NP cell group, BMSC with Ad-HIF-1α, BMSC with 
Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 groups showed 37 
fold, 4 fold, 6 fold, and 8 fold increase in mRNA expression of GLUT-1 
compared to that of BMSC.  
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(C) Different oxygen conditions at 96 hours 
In expression of HIF-1α and GLUT-1 mRNA, normoxic-hypoxic condition at 
96 hours demonstrated analogous pattern with those in continuous normoxic 
condition at 96 hours. (Figure 8) 
 
In continuous normoxic condition for 96 hours 
In HIF-1α mRNA expression, BMSC with Ad-HIF-1α, BMSC with Ad-HIF-
1α and Ad-GLUT-1, BMSC with Ad-GLUT-1 and NP cell group showed 
increased level of HIF-1α mRNA in order compared to that of BMSC.  
In GLUT-1 mRNA expression, BMSC with Ad-GLUT-1, NP cell, BMSC with 
Ad-HIF-1α and Ad-GLUT-1 and BMSC with Ad-HIF-1α group showed 
increased level of GLUT-1 mRNA expression in order compared to that of 
BMSC.  
 
In normoxic (48 hours) and hypoxic (48 hours) condition    
In HIF-1α mRNA expression, BMSC with Ad-HIF-1α and BMSC with Ad-
HIF-1α and Ad-GLUT-1 group revealed increased level of HIF-1α mRNA 
expression in order compared to that of BMSC.  
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In GLUT-1 mRNA expression, BMSC with Ad-HIF-1α and Ad-GLUT-1,  
BMSC with Ad-GLUT-1 and NP cell group demonstrated increased level of 
GLUT-1 mRNA expression in order compared to that of BMSC.  
 
In continuous hypoxic condition for 96 hours 
In HIF-1α mRNA expression, BMSC with Ad-HIF-1α and Ad-GLUT-1, and 
BMSC with Ad-GLUT-1 group demonstrated increased level of HIF-1α 
mRNA expression in order compared to that of BMSC. BMSC with Ad-mock 
and NP cell groups showed comparable level of HIF-1α mRNA expression 
with BMSC. BMSC with Ad-HIF-1α demonstrated decreased level of HIF-1α 
mRNA expression. 
In GLUT-1 mRNA expression, BMSC with Ad-GLUT-1, BMSC with Ad-
HIF-1α and Ad-GLUT-1, NP cell, BMSC with Ad-HIF-1α and BMSC with 
Ad-mock group showed increased level of GLUT-1 mRNA expression in 
order compared to that of BMSC.  
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D. Western blot  
In the HIF-1α protein analysis using anti-HIF-1α antibody, only BMSC with 
Ad-HIF-1α group showed positive result of HIF-1α protein. In additional 
analysis using anti-FLAG antibody, BMSC with Ad-HIF-1α and BMSC with 
Ad-HIF-1α and Ad-GLUT-1 group showed positive result of synthesized HIF-
1α protein by the transducted Ad-HIF-1α gene. The result for detecting the 
induced HIF-1α is shown in Figure 9. 
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Figure 9. Immunoblotting assay for HIF-1α protein.  
In the HIF-1α protein analysis using anti-HIF-1α antibody, only BMSC with Ad-
HIF-1α group showed positive result of HIF-1α protein.In additional analysis 
using anti-FLAG antibody, BMSC with Ad-HIF-1α and BMSC with Ad-HIF-1α 
and Ad-GLUT-1 group showed positive result of synthesized HIF-1α protein 
by transducted Ad-HIF-1α gene. It was due to relative strong detection of HIF-
1α protein in BMSC with Ad-HIF-1α compared to BMSC with Ad-HIF-1α and 
Ad-GLUT-1. BMSC: bone marrow mesenchymal stem cell, Ad: adenovirus, 
HIF-1α : hypoxia inducible factor-1 alpha, GLUT-1: glucose transporter-1  
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In the GLUT-1 protein analysis using anti-GLUT-1 antibody, all group 
showed positive result of GLUT-1 protein but only BMSC with Ad-GLUT-1 
group demonstrated strong positive result of GLUT-1 protein. In additional 
analysis using anti-FLAG antibody, BMSC with Ad-GLUT-1 and BMSC with 
Ad-HIF-1α and Ad-GLUT-1 group showed positive result of synthesized 
GLUT-1 protein by the transducted Ad-GLUT-1 gene. The result for detecting 
the synthesized GLUT-1 protein is shown in Figure.10. 
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Figure. 10 Immunoblotting assay for GLUT-1 protein.  
In the GLUT-1 protein analysis using anti-GLUT-1 antibody, all group showed 
positive result of GLUT-1 protein. In additional analysis using anti-FLAG 
antibody, BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 
group showed positive result of synthesized GLUT-1 protein by the 
transducted GLUT-1 gene. BMSC: bone marrow mesenchymal stem cell, Ad: 
adenovirus, HIF-1α : hypoxia inducible factor-1 alpha, GLUT-1: glucose 
transporter-1 
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E . RT-PCR of aggrecan and collagen type II 
(A) Normoxic condition at 24 and 48 hours 
In aggrecan mRNA expression at 24 hours, the BMSC with Ad-HIF-1α and 
Ad-GLUT-1 group showed 9 fold increase of aggrecan mRNA expression 
compared to that of BMSC. Other groups including NP cell, BMSC with Ad-
HIF-1α and BMSC with Ad-GLUT-1 showed 6 fold increases in aggrecan 
mRNA expression at 24 hours.  
In collagen type II mRNA expressionat 24 hours, all group showed from 
180% to 300% increased expression of collagen type II mRNA compared to 
that of BMSC. Also, the BMSC with Ad-HIF-1α and Ad-GLUT-1 group 
revealed the highest increase of collagen type II mRNA expression among all 
groups. Thest results are also shown in Figure 11.  
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Figure 11. RT-PCR result of aggrecan and collagen type II at 24 hours in vitro 
culture in normoxic condition. In the aggrecan mRNA expression, BMSC with 
Ad-HIF-1α and Ad-GLUT-1 group showed 9 fold increase of aggrecan mRNA 
expression compared to that of BMSC. In collagen type II mRNA expression, 
all group showed from 180% to 300% increased expression of collagen type II 
mRNA compared to that of BMSC.. 
BMSC with Ad-HIF-1α and Ad-GLUT-1 group showed highest increase in 
aggrecan and collagen type II mRNA expression in all groups.   
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In the aggrecan mRNA expression at 48 hours, NP cell showed 40% increase 
in aggrecan mRNA expression compared to that of BMSC. Other groups 
including BMSC with Ad-mock and BMSC with Ad-HIF-1α showed 10% 
decreases in aggrecan mRNA expression compared to that of BMSC.  
In collagen type II mRNA expression at 48 hours, BMSC with Ad-GLUT-1 
and BMSC with Ad-HIF-1α and Ad-GLUT-1 group showed 60% and 65%  
increase in expression of collagen type II mRNA compared to that of BMSC. 
Also, other groups showed comparable level of collagen type II mRNA  
expression as much as that of BMSC. (Figure 12)   
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Figure 12. RT-PCR result of aggrecan and collagen type II at 48 hours in vitro 
culture in normoxic condition.  
In the aggrecan mRNA expression, NP cell group showed 40% increase in 
aggrecan mRNA expression compared to that of BMSC. In collagen type II 
mRNA expression, BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-
GLUT-1 group showed 60% and 65% increase in expression of collagen type 
II mRNA compared to that of BMSC.   
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(B) Hypoxic conditions at 24 and 48 hours 
In the aggrecan mRNA expression at 24 hours, NP cell group demonstrated 
160% increase in aggrecan mRNA expression compared to that of BMSC.  
BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-
1α and Ad-GLUT-1 group showed 20%, 10% and 20% increased level of 
aggrecan mRNA expression compared to that of BMSC. BMSC with Ad-
mock showed 90% decreased level of aggrecan mRNA.  
In collagen type II mRNA expression at 24 hours, NP cell group showed 45% 
increase in collagen type II mRNA expression compared to that of BMSC.  
BMSC with Ad-mock group showed comparable level of collagen type II 
mRNA expression with BMSC. BMSC with Ad-HIF-1α, BMSC with Ad-
GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 group showed 30%, 
80% and 50% decreased expression of collagen type II mRNA expression. 
(Figure 13) 
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Figure 13. RT-PCR result of aggrecan and collagen type II at 24 hours in vitro 
culture in hypoxic condition.  
NP cell group demonstrated 160% increase in aggrecan mRNA expression 
compared to that of BMSC. In collagen type II mRNA expression, NP cell 
group showed 45% increase in collagen type II mRNA expression compared 
to that of BMSC. 
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In aggrecan mRNA expression at 48 hours, NP cell group demonstrated 
40% increase compared to that of BMSC. BMSC with Ad-mock and BMSC 
with Ad-HIF-1α demonstrated analogous level of aggrecan mRNA expression 
compared to that of BMSC. BMSC with Ad-GLUT-1 and BMSC with Ad-
HIF-1α and Ad-GLUT-1 group showed 60% and 20% decreased level of 
aggrecan mRNA expression compared to that of BMSC.  
In collagen type II mRNA expression at 48 hours, NP cell demonstrated 4.5 
fold increase in collagen type II mRNA expression compared to that of BMSC. 
BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-
1α and Ad-GLUT-1 group showed 100%, 80% and 90% increased expression 
of collagen type II mRNA expression. BMSC with Ad-mock group showed 
40% decrease of collagen type II mRNA expression. (Figure 14) 
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Figure 14. RT-PCR result of aggrecan and collagen type II at 48 hours in vitro 
culture in hypoxic condition.  
In the aggrecan mRNA expression, NP cell group demonstrated 40% increase 
compared to that of BMSC. In collagen type II mRNA expression, NP cell 
showed 4.5 fold increase in collagen type II mRNA expression compared to 
that of BMSC.   
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(C) Different oxygen conditions at 96 hours   
In matrix component mRNA expression, expression of aggrecan and collagen 
type II mRNA in continuous normoxic condition at 96 hours demonstrated 
analogous patterns with those in continuous hypoxic group. (Figure 15) 
 
In continuous normoxic condition for 96 hours 
In aggrecan and collagen type II mRNA expression, only NP cell group 
revealed increased level of aggrecan and collagen type II mRNA expression 
compared to that of BMSC. 
 
In normoxic (48 hours) and hypoxic (48 hours) condition    
In aggrecan mRNA expression, only NP cell group revealed significantly 
increased level of aggrecan mRNA expression compared to that of BMSC. 
Also, BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and BMSC with Ad-
HIF-1α and Ad-GLUT-1 showed increased expression of aggrecan mRNA 
compared to that of BMSC. 
In collagen type II mRNA expression, only NP cell group showed 
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significantly increased level of collagen type II mRNA expression compared 
to that of BMSC. Also, BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 and 
BMSC with Ad-HIF-1α and Ad-GLUT-1 showed increased expression of 
collagen type II mRNA compared to that of BMSC. 
 
In continuous hypoxic condition for 96 hours 
In aggrecan mRNA expression, NP cell, BMSC with Ad-HIF-1α, and  
BMSC with Ad-GLUT-1, BMSC with Ad-mock and BMSC with Ad-HIF-1α 
and Ad-GLUT-1 group showed significantly increased level of aggrecan 
mRNA expression in order compared to that of BMSC.  
In collagen type II mRNA expression, NP cell ,the BMSC with Ad-HIF-1α,  
BMSC with Ad-GLUT-1, BMSC with Ad-mock and BMSC with Ad-HIF-1α 
and Ad-GLUT-1 group revealed significantly increased level of collagen type 
II mRNA expression in order compared to that of BMSC.  
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2. In vivo  
In vivo study was perfomred according to the time table shown in Table 1. 
Each of result was described below. 
 
Table 1. Summary of group and time-table of in vivo experiment 
Time Control-1 
(BMSC) 
N=7 
 
Control-2 
(BMSC 
with 
Ad-mock) 
N=7 
Control-3 
(Nucleus 
pulposus) 
N=7 
BMSC 
with 
Ad 
-HIF-1a 
N=7 
BMSC 
with 
Ad 
-GLUT-1 
N=7 
BMSC 
With 
Ad 
-HIF-1a 
and Ad-
GLUT-1 
N=7 
0wk Alginate bead-BMSC complex insertion surgery 
into subcutaneous layers of DVA/1J mice (4 weeks old) 
2wk Histology  
(H & E, STRO for detection of human origin cell,  
Collagen type II, Aggrecan, Von kossa stain)  
RT-PCR  
(HIF-1α, GLUT-1 and Aggrecan) 
4wk Histology  
 (H & E, STRO for detection of human origin cell,  
Collagen type II, Aggrecan)  
RT-PCR  
(HIF-1α, GLUT-1 and Aggrecan) 
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A. RT-PCR at 2 and 4 weeks after implantation 
In HIF-1α mRNA expression at 2 weeks, all groups demonstrated increased 
expression of HIF-1α mRNA compared to that of BMSC. BMSC with Ad-
HIF-1α and Ad-GLUT-1, BMSC with Ad-GLUT-1, NP cell, BMSC with Ad-
mock and BMSC with Ad-HIF-1α groups showed 17 fold, 4 fold, 3 fold, 3 
fold and 2 fold increased level of HIF-1α mRNA expression compared to that 
of BMSC.  
In GLUT-1 mRNA expression at 2 weeks, BMSC with Ad-HIF-1α and Ad-
GLUT-1 showed 75% increased level of GLUT-1 mRNA expression 
compared to that of BMSC. BMSC with Ad-HIF-1α, NP cell and BMSC with 
Ad-GLUT-1 demonstrated comparable level of GLUT-1 mRNA expression 
with that of BMSC. But, BMSC with Ad-mock group showed 40% decrease 
in the GLUT-1 mRNA expression. (Figure 16)  
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Figure 16. RT-PCR result of HIF-1α and GLUT-1 at 2 weeks after 
subcutaneous implantation in DVA/1J mice.  
In HIF-1α mRNA expression at 2 weeks, all groups showed increased 
expression of HIF-1α mRNA compared to that of BMSC. In GLUT-1 mRNA 
expression, BMSC with Ad-HIF-1α and Ad-GLUT-1 revealed 75% increased 
level of GLUT-1 mRNA expression compared to that of BMSC. But, BMSC 
with Ad-mock group showed 40% decrease in the GLUT-1 mRNA expression.  
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In aggrecan mRNA expression at 2 weeks, all groups revealed increased 
expression of aggrecan mRNA compared to that of BMSC. BMSC with Ad-
HIF-1α and Ad-GLUT-1, BMSC with Ad-GLUT-1, NP cell, BMSC with Ad-
HIF-1α and BMSC with Ad-mock groups showed 250%, 70%, 60%, 20% and 
10% increased level of aggrecan mRNA expression compared to that of 
BMSC. (Figure 17) 
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Figure 17. RT-PCR result of aggrecan at 2 weeks after subcutaneous 
implantation in DVA/1J mice.  
In aggrecan mRNA expression, all groups showed increased expression of 
aggrecan mRNA compared to that of BMSC. BMSC with Ad-HIF-1α and Ad-
GLUT-1 showed 250% increased level of aggrecan mRNA expression 
compared to that of BMSC.  
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In vivo result at 4 weeks, all measured value was inconsistent with other in 
vivo and in vitro results. 
In HIF-1α mRNA expression at 4 weeks, all groups except BMSC with HIF-
1α demonstrated increased expression of HIF-1α mRNA compared to that of 
BMSC. BMSC with Ad-HIF-1α and Ad-GLUT-1 group demonstrated 6 fold 
increased level of HIF-1α mRNA compared to that of BMSC group. BMSC 
with Ad-GLUT-1, NP cell, and BMSC with Ad-mock and BMSC with Ad-
HIF-1α demonstrated 120%, 140% and 130% and 20% increased level of 
HIF-1α mRNA expression compared to that of BMSC.  
In GLUT-1 mRNA expression at 4 weeks, all groups except BMSC with HIF-
1α revealed increased expression of GLUT-1 mRNA compared to that of 
BMSC. BMSC with Ad-GLUT-1, NP cell, BMSC with Ad-HIF-1α and Ad-
GLUT-1 and BMSC with Ad-mock showed 40%, 40%, 18% and 24% 
increased level of GLUT-1 mRNA expression compared to that of BMSC.  
BMSC with Ad-HIF-1α demonstrated 60% decreased level of GLUT-1 
mRNA expression. (Figure 18) 
63 
 
 
64 
 
 
Figure 18. RT-PCR result of HIF-1α and GLUT-1 at 4 weeks after 
subcutaneous implantation in DVA/1J mice.  
All data showed inconsistent level of mRNA expression in HIF-1α and GLUT-1 
compared with other in vivo result at 2 weeks and in vitro results. In HIF-1α 
mRNA expression, all groups revealed increased expression of HIF-1α mRNA 
compared to that of BMSC. In GLUT-1 mRNA expression, all groups except 
BMSC with HIF-1α showed increased expression of GLUT-1 mRNA compared 
to that of BMSC.  
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In aggrecan mRNA expression at 4 weeks, all groups except BMSC with HIF-
1α showed increased expression of aggrecan mRNA compared to that of 
BMSC. NP cell, BMSC with Ad-GLUT-1, BMSC with Ad-mock and BMSC 
with Ad-HIF-1α and Ad-GLUT-1 groups showed 200%, 120%, 70% and 60% 
increased level of aggrecan mRNA expression compared to that of BMSC. 
(Figure 19) 
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Figure 19. RT-PCR result of aggrecan at 4 weeks after subcutaneous 
implantation in DVA/1J mice.  
Data demonstrated inconsistent level of mRNA expression in aggrecan 
compared with other in vivo result at 2 weeks and in vitro results. In aggrecan 
mRNA expression, all groups except BMSC with HIF-1α showed increased 
expression of aggrecan mRNA compared to that of BMSC. 
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B. Hematoxyline and Esosin stain 
All groups demonstrated invagination of cells between alginate structures 
with stain. No vascular ingrowth with BMSC with Ad-HIF-1α and BMSC 
with Ad-HIF-1α and Ad-GLUT-1 group due to Ad-HIF-1α gene transduction . 
(Figure 20) 
 In specimen at 2 weeks, BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1 
and BMSC with Ad-HIF-1α and Ad-GLUT-1 group showed larger cluster of 
cells between alginate components which were different from those of other 
groups.  
In specimen at 4 weeks, heterogeneous types of cell population with different 
cell sizes and small crushed alginate components were observed as the mice-
origin cells migrated and grew.  
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C. STRO stain 
All groups showed positive result for human mesenchymal stem cells, which 
means the retention and survival of human cells in the alginate beads. Cells 
with negative stain result were considered to come from the mice. 
 Although alginate components were degraded along with local immune 
reaction, the human origin cells were retained and presented as dark brown 
stained cells.  
Until 4 weeks, human originated cells were detected in the alginate-BMSCs 
complexes. (Figure 21) 
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D. Collagen type II stain 
In collagen type II stain in 2 weeks specimen, BMSC with Ad-HIF-1α, BMSC 
with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 group showed 
positive result of dark brown stained cells analogous to NP cell group which 
reflected the presence of collagen type II from differentiation of BMSC into 
NP cell. 
In collagen type II stain in 4 weeks specimen, BMSC with Ad-HIF-1α, BMSC 
with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 group also 
showed positive result of dark brown stained cells analogous to NP cell group 
which meant the retention of collagen type II from the differentiated NP cell. 
(Figure 22) 
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E. Aggrecan stain  
In aggrecan stain in 2 weeks specimen, BMSC with Ad-HIF-1α, BMSC with 
Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 group showed 
positive result of dark brown stained cells analogous to NP cell group which 
reflected the presence of aggrecan from differentiation of BMSC into NP cell. 
In the result of aggrecan stain in 4 weeks specimen, BMSC with Ad-HIF-1α, 
BMSC with Ad-GLUT-1 and BMSC with Ad-HIF-1α and Ad-GLUT-1 group 
also showed positive result of dark brown stained cells analogous to NP cell 
group, which meant the retention of aggrecan from differentiated NP cell. 
(Figure 23) 
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F. Von kossa 
All groups showed negative results for the detection of mineralization and 
calcification in the cytosol of differentiated cells and NP cell at 2weeks, which 
meant that no osteogenic differentiation of BMSC and NP cell by Ad-HIF-1α 
and Ad-GLUT-1 was progressed. (Figure 24.) 
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IV. DISCUSSION 
The hallmark of disc degeneration is the progressive loss of proteoglycan, 
which coincides with decreases in oxygen tension, free radical accumulation, 
decreased pH, and the increased activity of aberrant proteolytic enzyme.
22-24
  
Cell transplantation is one of the new therapy for degeneration of IVD that is 
based on the supplementation and/or replenishment of matrix-producing 
cells.
16
 Among the candidates including annulus fibrosus(AF) cell,
25
 elastic 
cartilage derived chondrocytes,
26
 autologus or allogenous NP,
27,28
 
immortalized human NP cell line,
29, 30
 mesenchymal stem cells (MSCs),
11, 15, 31
 
and embryogenic stem cells,
32
 MSCs have some merits including availability 
from many autologuos sources without significant donor site morbidity,
16, 33
 
expandability in culture to produce adequate numbers of cells for 
transplantation,
15, 34
 the preconditioning use of gene therapy to guide and 
stimulate MSCs toward the desired phenotype,
15, 16, 33, 35, 36
 better potentiality 
to survive and produce significant quantitied of matrix,
16, 36
 and immunologic 
privilege which enable the potential application of allogeneic MSCs as a 
therapeutic cell source.
37
 
78 
 
Still, researchers have not yet defined the NP cell by listing the specific gene 
expression profiles which describe NP cells. Instead, ‘chondrocyte-like cell’ is 
commonly used to call those specific cells. Confirmation of the characteristic 
markers of collagen type II, aggrecan and Sox-9 and the existence of HIF-1a 
can be used to distinguish NP cells from chondrocytes.
38
   
Some in vitro studies have been successfully performed to differentiate 
BMSC into NP cell using a co-culture system,
11, 25, 34, 35, 39, 40
 a cell carrier,
41
 
and a commercial scaffold.
42
  
Also, various results as to enhancement of paracrine effect,
43
 increase in 
revascularization
44
 and prolongation of stem cell survival
45
 were reported by 
preconditioning of MSCs via hypoxic condition
43, 45
 and chemical conditioned 
media.
44
  
Advances in stem cell biology have shown that differentiation of various 
MSCs depends primarily on the environment in which they are placed, 
suggesting hypoxic condition analogous to the unique original NP condition.
38, 
46, 47
  
Based on preconditioning gene transduction of BMSC on cell therapy, 
79 
 
phenotypic specific HIF-1 α and GLUT-1 were added in those cells to induce 
the NP specific differentiation in the present study. Additionally, stem cell 
differentiation after transduction of genes in normoxic condition, hypoxic 
condition and secondary hypoxic condition after normoxic preconditioning 
were compared in this study.    
HIF-1 is a heterodimeric transcription factor composed of a stable and 
constitutively expressed β-subunit and oxygen-sensitive α-subunit.48 The 
regulation of HIF-1α stability and degradation at the post-translational level 
under oxygen starvation has been investigated in numerous studies.
48-50
 HIF-1 
plays a major role in the pathobiology of other hypoxic condition such as 
ischemic heart disease, cancer, chronic lung disease and stroke.
51
 HIF-1 
mediated pathways influence angiogenesis, metabolic adaptation, innate 
immune response as well as survival and apoptosis of cells, and thus are 
critical factors in development, physiology and emergence of diseases like 
cancer and ischemia.
48
 Under condition of reduced oxygen availability, HIF-1 
regulates the expression of genes that mediate adaptive responses.
52, 53
 HIF-1 
was first identified in human cells as a regulator of erythropoietin, the 
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hormone that controls red-cell production by VEGF which stimulates 
angiogenesis and glycolytic enzyme which adapt cell metabolism to hypoxic 
condition.
51
 HIF-1 is present in all nucleated cells of all metazoan species and 
plays an important role in both erythropoiesis and vascularization. 
54
 
HIF-1α serves as a key transcriptional factor that regulates the expression of 
enzymes concerned with glycolysis, the activity of the TCA cycle and 
oxidative phosphorylation,
55, 56
 which mean adaptive responses to low oxygen 
tensions and nutrients deprivation.
57
  
Maintenance of HIF-1α showed differentiation of BMSC into the NP-like 
phenotype and increase of the anti-apoptosis ability in the rabbit model.
58
 Not 
only in the hypoxic condition but also in normoxic condition, HIF-1α serves 
to suppress oxidative phosphorylation, lower mitochondrial ATP generation, 
and promote glycolytic ATP and aggrecan synthesis.
59
 These activities are of 
considerable functional importance and point to the role of HIF-1α in 
promoting the synthesis of key water-binding molecules of the extracellular 
matrix, complexes that are required to maintain the biomechanical properties 
of the IVD.
59
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The half-life of the HIF-1α protein is extremely short in normoxic condition 
and is markedly prolonged during hypoxic stimulation.
60
 The mechanisms 
responsible for the rapid degradation of the HIF-1 α protein under normoxic 
condition were related to post-translational level modification of the α subunit 
such as ubiquitinization, acetylation, and phosphorylation,which influence 
protein stability and trans-activational function of HIF-1.
27, 48, 50, 61, 62
 Recently, 
additional several pre-translational regulative mechanisms of HIF-1 has 
reported including transcriptional and post-transcriptional modifications. In 
accordance with post-translational regulation, again the modification of the α 
subunit plays the major role.
48
  
In the present study, regardless of those degradative mechanism, the HIF-1α 
could be reproduced and remained to be effectively high level in the 
differentiated NP cell even in normoxic level, enough both to work as a 
phenotype specific differentiation introducer and to provide the syntechnic 
environment of BMSC differentiating into NP cell by gene therapy at once.  
Additionally, the mRNA expression patterns of marix protein and  
transducted gene were different depending on the oxygen condition. It means 
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that the preconditioning in the normoxic condition renders not only to induce 
the BMSC to differentiate into the NP cell but also to facilitate the synthesis 
of matrix protein among three different oxygen conditions. Also, theoretically,  
normoxic preconditioning could upregulate the expression of transducted 
HIF-1α gene and the hypoxic metabolic pathways of the differentiated cells 
enough to be easily adapted in hypoxic condition even prior to expose them in 
hypoxic condition .   
Therefore, the cell metabolism and possibly survival of induced NP cell 
could be affected favorably when the differentiation from BMSC into NP cell 
by the trasnducted HIF-1α was initiated, especially when BMSC with specific 
genes are placed in the preconditioning normoxic status and secondary 
hypoxic status.  
Based on these merits, the pre-requisites of tissue engineering and 
regeneration could be gratified with the originality and reinforced durability 
of differentiated NP cell. Also, distinguished from the secondary increase of 
HIF-1 α in hypoxic condition,38 the direct expression of transducted HIF-1α 
gene in the normoxic condition was confirmed to function properly in the 
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present study, which supports functionality of HIF-1α in NP under normoxic 
condition
48, 59
 Until now, the regulation of HIF-1α under normoxia is essential 
interest regarding its distribution and regulation in cancer cells and only a few 
publications about non-hypoxic condition have been published.
27
  
As mentioned to be the NP cell-markers in the previous studies,
34, 63, 64
 
collagen type II and aggrecan were increased as a result of transducted HIF-
1α and GLUT-1 expression. Furthermore, based on the histological staining 
including hematoxyline and eosin, alcian blue, and Von kossa, the regulatory 
function of mineralization by HIF-1 in the IVD was detected which is 
correlating with recent studies.
65, 66
 
Glucose transport and metabolism are hypoxia regulated processes in the 
avascular regions of the human IVD and that degeneration affects the 
expression of glucose transporters.
57
 The result confirmed HIF-1α , GLUT-
1,3,9 mRNA expression and co-expression of each GLUT isoform with HIF-
1α in the NP. Also, immunochemistry demonstrated regional differences in 
GLUT expression, with the highest expression being in the NP. Regional 
differences in GLUT protein distribution was demonstrated reflecting hypoxic 
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status between NP and AF.
57
 The result show that HIF-1α mRNA and the 
hypoxia responsive GLUT-1 genes are co-expressed in normal human IVD 
and that in the NP an increase in HIF-1α mRNA was associated with an 
increase in both GLUT-1 mRNA expression.
57
  
It is reasonable to suggest that up-regulation of GLUT-1 in early degeneration 
may be a metabolic adaptation to the hypoxic condition, because the uptake of 
glucose by disc cell is a fundamental process.
57
 One of the consequences of 
low oxygen tension in the NP is the reliance on glycolysis for energy 
generation,
59
 known as one way in which HIF-1α promotes cell survival under 
hypoxic conditions is by mediating a switch from oxidative to glycolytic 
metabolism.
51
 Glucose was converted to pyruvate by the glycolytic enzyme, 
which can be converted either to acetyl coenzyme A (CoA) for oxidation in 
the tricarboxylic acid cycle or to latate as a glycolytic end product.
8
  
Immunochemical data from that study, in the NP, most hypoxic region of the 
IVD, the number of cells immunopositive for the GLUT-1, the most 
ubiquitous of the GLUTs, this increase continue to late stage of degeneration, 
which considered to be a response to the lack of available glucose within the 
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extracellular matrix.
57
 
As a result of our investigation on HIF-1α and GLUT-1, GLUT-1 alone could 
induce the synthesis of NP specific matrix proteins in a certain amount.  
According to the well-known sequence between HIF-1α and GLUT-1,57 HIF-
1α is not induced by GLUT-1 in the present study. Therefore, the commonly 
accepted concept on NP cell, which explains itself as a chondrocyte like cell 
with a necessary phenotypic marker of HIF-1α and NP specific matrix 
protiens such as collagen type II, aggrecan and SOX-9,
38
 could not be 
satisfied with transduction of GLUT-1 alone in normoxic condition. Another 
preconditioning in the hypoxic condition might be necessary to induce BMSC 
into NP cell with transduction of GLUT-1 gene alone. Nevertheless, 
transduction of GLUT-1 as a phenotypic marker of NP cell showed 
considerable effect on synthesis of NP matrix in the present study. Also, 
transducted GLUT-1 gene in combination with Ad-HIF-1α showed some 
additional effects in the synthesis of NP specific matrix proteins in a certain 
circumstance such as the result of in vivo 2 weeks. 
It is a common phenomenon that the expression of HIF-1α was reduced when 
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the GLUT-1 gene had transducted alone or in combination with Ad-HIF-1 α 
regardless of oxygen status at 96 hour in vitro culture, discerning from the 48 
hour in vitro result. It might be derived from the sequential relation between 
HIF-1α and GLUT-1,57 and possible negative feedback by GLUT-1 on HIF-1α 
expression could be postulated and further study on this mention is strongly 
necessitated.    
Although the present study could be considered as the highlighting study for 
the potential for BMSC therapy in degenerative IVD using NP specific HIF-1 
α and GLUT-1 via adenoviral vector, many questions are still remained to be 
solved. The estimated survival after transplantation into the human 
degenerative IVD, extensibility of the survival of grafts in combination with 
the growth factor or blocking specific enzyme gene such as BMP-2 and 
TIMP
67
 should be investigated. But most of all, the safety control the viral 
vector related risk during the human trial should be answered.
68
 
As for containing scaffold, alginate beads scaffold was used during 
differentiation of the BMSC into NP cell which proved to be effective and 
safe to maintain the viability of human BMSC.
69
 Considering the 
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characteristic of alginate bead in differentiation of BMSC into NP cell, 
environmental comparability could be induced compared with natural course 
of the embryogenic differentiation and degeneration of NP. Because, the 
alginate beads are three dimensional tissue engineering constructs, nutrients 
and oxygen are replenished by diffusion.
69
 Therefore, a nutrient gradient 
developes where cells on the exterior portions of scaffolds receive sufficient 
nutrients, whereas cells on the interior of scaffolds are deprived of nutrients 
and are exposed to hypoxic condition.
69
 Aggregated alginate constructs were 
proved to be of sufficient strength for the engineering of tissue such as 
cartilage,
70, 71
 non-load bearing bone,
72
 and skelektal muscle.
73
 As a result of 
in vivo experiment, spherical alginate beads were deformed into long oval 
sphere due to subcutaneous pressure of mice, which resulted in the only thin 
layers of enveloped cells clusters left. Therefore, an additional mechanical 
support of alginate beads or pressure-free space to encourage the cell 
differentiation and volumetric growth is required.   
In summary, an effort to differentiate the BMSC into the designated NP cell 
by transducted HIF-1 and GLUT-1 in vivo and in vitro was successful. For the 
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future study, the survival and cell metabolic change related to the 
preconditioning oxygen status and three dimensional growth should be 
investigated thoroughly. 
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V. CONCLUSION 
Transduction of each gene of the HIF-1α and GLUT-1 by adenovirus proved 
to be effective to induce the differentiation of BMSC into NP cell in vitro and 
in vivo. The phenotypic expression and matrix synthesis depending on the 
combination of the transducted genes in company with the oxygen 
preconditioning were consistent and expectable. Thus this result show us new 
suggestions in the treatment of degenerative IVD in the way of differentiation 
of new NP-like cell from BMSC and possible modulation of the cell 
metabolism based on transduction of HIF-1α and GLUT-1 genes.   
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ABSTRACT(IN KOREAN) 
Discogenic differentiation of human bone marrow mesenchymal stem cell 
with Adenovirus mediated  
glucose transporter-1 and hypoxia inducible factor-1α gene therapy  
 
<지도교수  이 환 모> 
 
연세대학교 대학원 의학과 
 
이 병 호 
 
연령이 증가하고 퇴행성 변화가 진행됨에 따라 디스크는 점차 기질
적인 변화와 형태학적인 변화 그리고, 세포 수준의 변화를 겪게 된
다. 이런 디스크의 퇴행성 변화를 치료하는 이상적인 방법으로는 손
상받은 디스크 조직을 원래의 디스크와 생물학적 및 생화학적으로 
비슷하거나 더 나은 성질을 가지는 기질적 구조로 수리 및 대체하
는 방법이 있다. 최근, 생물학적으로 손상된 조직을 수리하거나, 디
스크의 기능을 재생하는 분야에 대한 연구가 유전자치료, 성장인자 
주입, 세포 기반 조직 공학등의 분야에서 활발하게 이뤄지고 있다.  
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Hypoxia inducible factor-1α (이하 HIF-1α) 는 디스크 내에서 에
너지 대사와 세포의 생존을 조절하는 중요한 인자이며, 또한 인간의 
디스크 세포의 특징을 나타내는 표현형 인자로 밝혀진 바 있다. 
Glucose transporter-1(이하 GLUT-1)은 디스크의 특징적인 환경
인 저산소 환경에서 디스크 세포내로의 glucose의 운반을 촉진하는 
역할을 하며, 역시 HIF-1α와 마찬가지로 디스크 세포의 표현형 인
자로 사용될 수 있다.  
본 연구에서는 이런 디스크 세포에 특징적인 표현형 인자인 HIF-
1α 와 GLUT-1을 아데노 바이러스를 이용한 골수 중간엽 줄기세포 
(BMSC)로의 유전자 전달을 통해 디스크 세포로의 분화 가능성에 
대해 연구하고자 실험을 진행하였다.  
BMSC 는 척추관 협착증 환자의 수술이 진행되는 동안 해당환자에 
게서 환자의 술전 동의 하에 채집되었다.  
대조군과 실험군을 설정한 후 각각 시험관내 (in vitro) 와 생체내 
(in vivo) 실험을 동시에 진행하였다. 시험관내 실험에서는 디스크 
세포를 양성 대조군으로 설정하였고, BMSC를 음성 대조군으로 설
정하여, 각각의 대조군과 주입된 유전자 등의 조합하여 총 6군에 대
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하여 실험을 진행하였다 
아데노바이러스를 이용한 유전자 전달 및 그에 따른 BMSC의 디스
크 세포로의 분화는 각각 reverse-trasctiption polymerase chain 
reaction (RT-PCR) 과 조직학적 검사등을 통해 확인하였다.  
생체내 실험에서는 alginate-BMSC 복합체를 mice(DVA/1J)의 배부
에 피하 이종 이식을 시행 후, 각각 2 주 및 4 주에 희생시켜 조직
을 채취 후 조직학적 검사를 시행하였다. 최종 산물에 대해 
aggrecan과 collagen type II 존재를 확인하여 디스크 세포로의 분
화를 검증하였다.  
시험관내 실험의 각 24시간 및 48 시간 결과, BMSC with Ad-HIF-
1α 와 BMSC with Ad-GLUT-1 그리고 BMSC with Ad-HIF-1α 
and Ad-GLUT-1 군에서 aggrecan과 GLUT-1 그리고 collagen 
type II가 디스크 세포와 비슷한 정도의 mRNA를 발현하는 것으로 
확인되었다. 그러나 HIF-1α의 mRNA의 발현은 HIF-1α의 유전자를 
주입한 BMSC with Ad-HIF-1α 와 BMSC with Ad-HIF-1α and 
Ad-GLUT-1 군에서만 증가하는 것으로 관찰되었다.  
각각 96시간 동안 산소 농도를 다르게 하여 배양한 실험에서는,   
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48시간 저 산소 농도 배양 후 48시간 정상 산소농도에서 배양한 군
에서는 정상산소 농도를 유지한 군에서 각각의 HIF-1α와 GLUT-1
의 mRNA 발현은 96시간동안 정상 산소 농도를 유지한 군과 비슷
하게 나타났다. 하지만 기질 합성에서는 aggrecan과 제2형 콜라겐
의 mRNA발현이 96시간동안 저산소 농도 배양을 유지한 군과 비슷
한 양상으로 발현되었다.  
생체내 실험 결과로는, 제2형 콜라겐과 aggrecan에 대한 양성 염색 
소견이 각각 BMSC with Ad-HIF-1α, BMSC with Ad-GLUT-1, 
BMSC with Ad-HIF-1α and Ad-GLUT-1 군에서 모두 디스크 세
포 군과 비슷한 정도로 발현되었다.   
따라서 본 연구에서의 HIF-1α와 GLUT-1 유전자의 아데노바이러
스를 통한 BMSC로의 전달을 통한 디스크형 세포로의 분화 유도는 
시험관내 와 생체내 실험 모두에서 성공적이었음에 대해 확인하였
다.  
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